SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-13-000757
Filing Date
2013-01-04
Accepted
2013-01-04 16:06:13
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A a12-29921_1s3a.htm S-3/A 560145
2 EX-23.1 a12-29921_1ex23d1.htm EX-23.1 4318
3 GRAPHIC g299211ba11i001.jpg GRAPHIC 16723
4 GRAPHIC g299211ba11i002.gif GRAPHIC 5243
5 GRAPHIC g299211ba07i001.jpg GRAPHIC 5835
6 GRAPHIC g299211ba07i002.gif GRAPHIC 5243
  Complete submission text file 0001104659-13-000757.txt   611749
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-185647 | Film No.: 13511812
SIC: 2835 In Vitro & In Vivo Diagnostic Substances